Avoro Capital Advisors LLC Investment Portfolio — 13F Data

CIK: 0001633313

Momentum followerQuality / disciplined sizingDiversified strategy

Total reported value

$10.2B

Reporting period: 2026-03-31 · Number of holdings: 33

Avoro Capital Advisors LLC disclosed 33 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $10.2B and a quarterly turnover rate of 29.8%.

Browse other institutions with $10B to $100B AUM Browse other institutions starting with "A"

Personality snowflake

Concentration: 30.03
Portfolio Stability: 29.78
Momentum/Contrarian: 100
Sector conviction: 0
Diversification: 60
Sizing Uniformity: 88.62

Sector classification currently covers about 51% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Add UTHR
+15.5%　$300.0M
Add APLSUSD
0.0%　$184.7M
Trim GPCR
0.0%　-$140.0M
Add 430
+30.9%　$124.5M
Trim ARGX
+1.0%　-$102.3M
Trim MDGL
+0.6%　-$100.8M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 30 holdings (of 33 total)

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	UTHR	United Therapeutics CORP	Stock-Healthcare	15.44%	+2.96%	+15.50%
2	ASND	Ascendis Pharma A/S	Stock-Other	11.39%	+0.67%	-1.91%
3	MDGL	Madrigal Pharmaceuticals INC	Stock-Healthcare	9.36%	-0.99%	+0.59%
4	KRYS	Krystal Biotech INC	Stock-Healthcare	7.34%	+0.34%	—
5	ARGX	Argenx Se - Adr	Stock-Healthcare	7.18%	-1.00%	+1.01%
6	ARWR	Arrowhead Pharmaceuticals In	Stock-Healthcare	6.60%	-0.33%	+0.71%
7	KYMR	Kymera Therapeutics INC	Stock-Other	6.12%	+0.40%	—
8	APLSUSD	Apellis Pharmaceuticals INC	Stock-Other	4.84%	+1.82%	—
9	260	Centessa Pharmaceuticals-adr	Stock-Other	4.47%	+0.89%	-21.47%
10	CELC	Celcuity INC	Stock-Other	3.82%	+0.77%	+14.91%
11	XENE	Xenon Pharmaceuticals INC	Stock-Other	3.31%	+0.92%	+6.51%
12	GPCR	Structure Therapeutics INC	Stock-Other	3.11%	-1.37%	—
13	430	Terns Pharmaceuticals INC	Stock-Other	2.95%	+1.22%	+30.92%
14	VERA	Vera Therapeutics INC	Stock-Other	2.33%	-0.60%	—
15	RVMD	Revolution Medicines INC	Stock-Healthcare	2.24%	+0.54%	+8.04%
16	CYTK	Cytokinetics INC	Stock-Healthcare	2.16%	+2.16%	NEW
17	OCUL	Ocular Therapeutix INC	Stock-Other	1.03%	-0.26%	+14.26%
18	DMRA	Damora Therapeutics INC	Stock-Other	0.96%	+0.96%	NEW
19	QURE	uniQure N.V.	Stock-Other	0.96%	-0.49%	-3.10%
20	TSHA	Taysha Gene Therapies INC	Stock-Other	0.95%	-0.22%	—
21	DFTX	Definium Therapeutics INC	Stock-Other	0.93%	+0.93%	NEW
22	SLNOEUR	Soleno Therapeutics INC	Stock-Other	0.76%	-0.56%	-20.69%
23	ALKS	Alkermes plc	Stock-Healthcare	0.42%	+0.04%	-14.29%
24	SEPN	Septerna INC	Stock-Other	0.32%	-0.05%	—
25	VRDN	Viridian Therapeutics INC	Stock-Other	0.29%	-0.17%	—
26	GHRS	GH Research PLC	Stock-Other	0.25%	+0.03%	—
27	AVTX	Avalo Therapeutics INC	Stock-Other	0.21%	+0.21%	NEW
28	LXEO	Lexeo Therapeutics INC	Stock-Other	0.11%	-0.21%	-43.18%
29	WHWK	Whitehawk Therapeutics INC	Stock-Other	0.10%	+0.03%	—
30	MNKD	Mannkind CORP	Stock-Other	0.05%	-0.20%	-50.50%

Portfolio Performance

Performance for Q3 2026

+17.1%

Performance Last 4 Quarters

+91.1%

Based on 66% of reported portfolio value with available pricing

Stdev: +25%
Beta: +0.59
Alpha: +17.2%
Max Drawdown: -22.4%
Annualized Perf: +27.8%
Batting Avg vs S&P: +48.3%
Sortino: +2.03
Stutzer: +0.33
Treynor: +0.47
Sterling: +1.19
Calmar: +1.24
Information Ratio: +0.41
Tracking Error: +24.4%
Stdev Down: +13.7%
Winning Months %: +69%
Losing Months %: +31%
Best 12 Months: +107.3%
Worst 12 Months: -12.2%
Efficiency Ratio: +0.47
Sharpe: +1.11
Stdev Sectors: 0%
Skewness: -0.11
Kurtosis: -0.38
Upside Potential: +3.64

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	33	$10.2B	30	1UTHR 2ASND 3MDGL Top holdings2026-03-31 1.UTHR 2.ASND 3.MDGL 4.KRYS 5.ARGX 6.ARWR 7.KYMR 8.APLSUSD 9.260 10.CELC
2025-12-31	34	$10.2B	51	1UTHR 2ASND 3MDGL Top holdings2025-12-31 1.UTHR 2.ASND 3.MDGL 4.ARGX 5.KRYS 6.ARWR 7.KYMR 8.GPCR 9.RNAGBP 10.260
2025-09-30	32	$7.7B	48	1ASND 2UTHR 3MDGL Top holdings2025-09-30 1.ASND 2.UTHR 3.MDGL 4.ARGX 5.KRYS 6.ARWR 7.KYMR 8.N5749R 9.RNAGBP 10.APLSUSD
2025-06-30	30	$5.7B	0	1ASND 2UTHR 3ARGX Top holdings2025-06-30 1.ASND 2.UTHR 3.ARGX 4.MDGL 5.KRYS 6.KYMR 7.APLSUSD 8.RNAGBP 9.MLTX 10.AKRO
2025-03-31	33	$6.4B	100	1UTHR 2ASND 3ARGX Top holdings2025-03-31 1.UTHR 2.ASND 3.ARGX 4.MDGL 5.KRYS 6.2655787D 7.APLSUSD 8.RNAGBP 9.XENE 10.SLNOEUR
2024-12-31	39	$7.1B	0	1UTHR 2ARGX 3ASND Top holdings2024-12-31 1.UTHR 2.ARGX 3.ASND 4.MDGL 5.KRYS 6.APLSUSD 7.SRPT 8.ITCIEUR 9.VERA 10.XENE
2024-09-30	36	$6.9B	0	1UTHR 2ASND 3ARGX Top holdings2024-09-30 1.UTHR 2.ASND 3.ARGX 4.KRYS 5.MDGL 6.APLSUSD 7.SRPT 8.RNAGBP 9.AM6 10.ITCIEUR
2024-06-30	41	$7.5B	0	1UTHR 2MDGL 3ASND Top holdings2024-06-30 1.UTHR 2.MDGL 3.ASND 4.ARGX 5.SRPT 6.KRYS 7.APLSUSD 8.BMRN 9.CERE1EUR 10.XBI
2024-03-31	46	$8.6B	0	1UTHR 2APLSUSD 3ASND Top holdings2024-03-31 1.UTHR 2.APLSUSD 3.ASND 4.SRPT 5.MDGL 6.ARGX 7.KRYS 8.XBI 9.BMRN 10.AM6
2023-12-31	42	$7.2B	0	1APLSUSD 2UTHR 3ASND Top holdings2023-12-31 1.APLSUSD 2.UTHR 3.ASND 4.ARGX 5.MDGL 6.SRPT 7.BMRN 8.XBI 9.AM6 10.CERE1EUR
2023-09-30	46	$6.4B	0	1G461882UTHR 3ARGX Top holdings2023-09-30 1.G46188 2.UTHR 3.ARGX 4.SRPT 5.APLSUSD 6.SGENUSD 7.ASND 8.BMRN 9.AM6 10.KRYS
2023-06-30	43	$7.4B	0	1APLSUSD2G461883UTHR Top holdings2023-06-30 1.APLSUSD 2.G46188 3.UTHR 4.SRPT 5.ARGX 6.MDGL 7.BMRN 8.AM6 9.SGENUSD 10.ASND
2023-03-31	41	$6.7B	0	1G461882APLSUSD 3UTHR Top holdings2023-03-31 1.G46188 2.APLSUSD 3.UTHR 4.SRPT 5.ARGX 6.MDGL 7.BMRN 8.SGENUSD 9.ASND 10.AM6
2022-12-31	36	$6.7B	0	1UTHR2G461883APLSUSD Top holdings2022-12-31 1.UTHR 2.G46188 3.APLSUSD 4.MDGL 5.ARGX 6.SRPT 7.ASND 8.BMRN 9.AM6 10.ALNY
2022-09-30	39	$5.4B	0	1APLSUSD 2UTHR 3ARGX Top holdings2022-09-30 1.APLSUSD 2.UTHR 3.ARGX 4.MRTXEUR 5.SRPT 6.G46188 7.BMRN 8.ASND 9.AM6 10.SGENUSD
2022-06-30	40	$5.1B	0	1UTHR 2ARGX 3APLSUSD Top holdings2022-06-30 1.UTHR 2.ARGX 3.APLSUSD 4.G46188 5.MRTXEUR 6.AM6 7.BMRN 8.SGENUSD 9.SRPT 10.ASND
2022-03-31	43	$5.5B	0	1G461882UTHR 3APLSUSD Top holdings2022-03-31 1.G46188 2.UTHR 3.APLSUSD 4.MRTXEUR 5.ARGX 6.XBI 7.ASND 8.SRPT 9.BMRN 10.ALNY
2021-12-31	41	$5.9B	0	1G461882MRTXEUR 3UTHR Top holdings2021-12-31 1.G46188 2.MRTXEUR 3.UTHR 4.APLSUSD 5.ARGX 6.SRPT 7.ASND 8.BMRN 9.AM6 10.ALNY
2021-09-30	52	$6.4B	0	1G461882MRTXEUR 3XLRN Top holdings2021-09-30 1.G46188 2.MRTXEUR 3.XLRN 4.UTHR 5.ASND 6.ARGX 7.SRPT 8.IOVA 9.ARNAEUR 10.AM6
2021-06-30	46	$5.7B	100	1G461882MRTXEUR 3UTHR Top holdings2021-06-30 1.G46188 2.MRTXEUR 3.UTHR 4.XLRN 5.ARGX 6.ARNAEUR 7.ASND 8.IOVA 9.SRPT 10.ALNY
2021-03-31	46	$5.8B	43	1G461882MRTXEUR 3UTHR Top holdings2021-03-31 1.G46188 2.MRTXEUR 3.UTHR 4.XLRN 5.VRTX 6.ARNAEUR 7.ARGX 8.IOVA 9.043351 10.MDGL
2020-12-31	44	$5.8B	72	1MRTXEUR2G461883UTHR Top holdings2020-12-31 1.MRTXEUR 2.G46188 3.UTHR 4.IOVA 5.ARNAEUR 6.ASND 7.SRPT 8.ARGX 9.AM6 10.XLRN
2020-09-30	46	$7.0B	53	1IMMU 2MRTXEUR3G46188 Top holdings2020-09-30 1.IMMU 2.MRTXEUR 3.G46188 4.IOVA 5.ASND 6.MYOKEUR 7.ARGX 8.SRPT 9.ARNAEUR 10.AM6
2020-06-30	45	$5.1B	59	1IMMU 2MRTXEUR3G46188 Top holdings2020-06-30 1.IMMU 2.MRTXEUR 3.G46188 4.IOVA 5.SRPT 6.ASND 7.BMRN 8.ARGX 9.MYOKEUR 10.AM6
2020-03-31	43	$3.0B	41	1IMMU 2MRTXEUR 3IOVA Top holdings2020-03-31 1.IMMU 2.MRTXEUR 3.IOVA 4.ASND 5.BMRN 6.SRPT 7.G46188 8.KPTIEUR 9.ARGX 10.CNST
2019-12-31	32	$3.4B	57	1IMMU 2MRTXEUR 3ASND Top holdings2019-12-31 1.IMMU 2.MRTXEUR 3.ASND 4.IOVA 5.SRPT 6.CNST 7.BMRN 8.ARGX 9.G46188 10.QURE
2019-09-30	33	$2.4B	30	1MRTXEUR 2IMMU 3IOVA Top holdings2019-09-30 1.MRTXEUR 2.IMMU 3.IOVA 4.ASND 5.BMRN 6.023111 7.SRPT 8.G46188 9.ARGX 10.AM6
2019-06-30	35	$2.9B	42	1MRTXEUR 2IMMU 3IOVA Top holdings2019-06-30 1.MRTXEUR 2.IMMU 3.IOVA 4.ASND 5.SRPT 6.BMRN 7.023111 8.AM6 9.ARGX 10.ZGNXEUR
2019-03-31	32	$2.3B	45	1IMMU 2MRTXEUR 3ASND Top holdings2019-03-31 1.IMMU 2.MRTXEUR 3.ASND 4.023111 5.SRPT 6.AM6 7.G4617B 8.ZGNXEUR 9.ARGX 10.IOVA
2018-12-31	35	$1.7B	40	1IMMU 2MRTXEUR 3SRPT Top holdings2018-12-31 1.IMMU 2.MRTXEUR 3.SRPT 4.ASND 5.BMRN 6.AM6 7.IOVA 8.G4617B 9.ARGX 10.023111
2018-09-30	46	$2.2B	36	1IMMU 2MRTXEUR 3SRPT Top holdings2018-09-30 1.IMMU 2.MRTXEUR 3.SRPT 4.ASND 5.BMRN 6.AM6 7.MDGL 8.IOVA 9.29269A 10.G4617B
2018-06-30	44	$2.6B	63	1IMMU 2MRTXEUR 3BMRN Top holdings2018-06-30 1.IMMU 2.MRTXEUR 3.BMRN 4.AM6 5.ASND 6.MDGL 7.SRPT 8.IOVA 9.G4617B 10.29269A
2018-03-31	58	$2.1B	50	1IMMU 2AM6 3BMRN Top holdings2018-03-31 1.IMMU 2.AM6 3.BMRN 4.IOVA 5.MRTXEUR 6.ASND 7.GBTUSD 8.05366U 9.TGTX 10.G4617B
2017-12-31	52	$1.5B	47	1IMMU 2AM6 3BMRN Top holdings2017-12-31 1.IMMU 2.AM6 3.BMRN 4.MRTXEUR 5.CLVSEUR 6.GBTUSD 7.ARRYEUR 8.ASND 9.05366U 10.G4617B
2017-09-30	45	$1.3B	67	1IMMU 2AM6 3KRG Top holdings2017-09-30 1.IMMU 2.AM6 3.KRG 4.ARRYEUR 5.CLVSEUR 6.MDCOUSD 7.ASND 8.BMRN 9.PCRX 10.G4617B
2017-06-30	47	$792.0M	59	1IMMU 2KRG 3AM6 Top holdings2017-06-30 1.IMMU 2.KRG 3.AM6 4.T8S 5.BMRN 6.MDCOUSD 7.DERMEUR 8.87960W 9.ARRYEUR 10.IOVA
2017-03-31	47	$782.8M	81	1IMMU 2T8S 3MDCOUSD Top holdings2017-03-31 1.IMMU 2.T8S 3.MDCOUSD 4.ACAD 5.BMRN 6.DERMEUR 7.AM6 8.ARRYEUR 9.LION 10.GBTUSD
2016-12-31	44	$495.0M	53	1ACAD 2IMMU 3BMRN Top holdings2016-12-31 1.ACAD 2.IMMU 3.BMRN 4.LION 5.T8S 6.SRPT 7.M74231 8.DERMEUR 9.AERIEUR 10.NBIX
2016-09-30	48	$569.9M	64	1SRPT 2BMRN 3LION Top holdings2016-09-30 1.SRPT 2.BMRN 3.LION 4.T8S 5.AGENEUR 6.AM6 7.DERMEUR 8.ACAD 9.NBIX 10.IMMU
2016-06-30	48	$450.0M	81	1T8S 2LION315089R Top holdings2016-06-30 1.T8S 2.LION 3.15089R 4.BMRN 5.BMY 6.SRPT 7.NBIX 8.DERMEUR 9.AM6 10.IMMU
2016-03-31	41	$286.7M	81	1MRTXEUR 2AM6 3SRPT Top holdings2016-03-31 1.MRTXEUR 2.AM6 3.SRPT 4.BMRN 5.GILD 6.NBIX 7.LION 8.15089R 9.MODV 10.BMY
2015-12-31	31	$290.3M	52	1MRTXEUR 2AM6 3LION Top holdings2015-12-31 1.MRTXEUR 2.AM6 3.LION 4.LJPC 5.SRPT 6.71426V 7.DERMEUR 8.87960W 9.VNDA 10.SRNE
2015-09-30	36	$384.6M	61	1AM6 2MRTXEUR 3VNDA Top holdings2015-09-30 1.AM6 2.MRTXEUR 3.VNDA 4.M74231 5.LJPC 6.ACAD 7.71426V 8.LION 9.SRNE 10.SRPT
2015-06-30	31	$363.1M	86	1AM6 2SRNE 3MRTXEUR Top holdings2015-06-30 1.AM6 2.SRNE 3.MRTXEUR 4.LION 5.682324 6.ACAD 7.AGENEUR 8.VNDA 9.LJPC 10.449575
2015-03-31	33	$260.6M	91	1AM6 2LION 3SRNE Top holdings2015-03-31 1.AM6 2.LION 3.SRNE 4.151020 5.71426V 6.079481 7.AGENEUR 8.EBS 9.MRTXEUR 10.LJPC
2014-12-31	30	$147.6M	0	1AM62M8737E3756207 Top holdings2014-12-31 1.AM6 2.M8737E 3.756207 4.71426V 5.AGENEUR 6.SRNE 7.EBS 8.556099 9.682324 10.079481

Holding changes this quarter

Avoro Capital Advisors LLC's most significant position changes for 2026-03-31: Sold out: Avidity Biosciences INC (RNAGBP); Sold out: Ss Spdr S&p Biotech ETF (XBI); New buy: Cytokinetics INC (CYTK); New buy: Damora Therapeutics INC (DMRA); New buy: Definium Therapeutics INC (DFTX).

Position changes disclosed by Avoro Capital Advisors LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	UTHR	United Therapeutics CORP	+3%	+15.50%	Add
2	APLSUSD	Apellis Pharmaceuticals INC	+1.8%	—	Unchanged
3	430	Terns Pharmaceuticals INC	+1.2%	+30.92%	Add
4	XENE	Xenon Pharmaceuticals INC	+0.9%	+6.51%	Add
5	260	Centessa Pharmaceuticals-adr	+0.9%	-21.47%	Trim
6	CELC	Celcuity INC	+0.8%	+14.91%	Add
7	ASND	Ascendis Pharma A/S	+0.7%	-1.91%	Trim
8	RVMD	Revolution Medicines INC	+0.5%	+8.04%	Add
9	KYMR	Kymera Therapeutics INC	+0.4%	—	Unchanged
10	KRYS	Krystal Biotech INC	+0.3%	—	Unchanged
11	ALKS	Alkermes plc	0%	-14.29%	Trim
12	WHWK	Whitehawk Therapeutics INC	0%	—	Unchanged
13	GHRS	GH Research PLC	0%	—	Unchanged
14	SEPN	Septerna INC	-0.1%	—	Unchanged
15	VRDN	Viridian Therapeutics INC	-0.2%	—	Unchanged
16	MNKD	Mannkind CORP	-0.2%	-50.50%	Trim
17	LXEO	Lexeo Therapeutics INC	-0.2%	-43.18%	Trim
18	TSHA	Taysha Gene Therapies INC	-0.2%	—	Unchanged
19	OCUL	Ocular Therapeutix INC	-0.3%	+14.26%	Add
20	ARWR	Arrowhead Pharmaceuticals In	-0.3%	+0.71%	Add
21	QURE	uniQure N.V.	-0.5%	-3.10%	Trim
22	SLNOEUR	Soleno Therapeutics INC	-0.6%	-20.69%	Trim
23	VERA	Vera Therapeutics INC	-0.6%	—	Unchanged
24	MDGL	Madrigal Pharmaceuticals INC	-1%	+0.59%	Add
25	ARGX	Argenx Se - Adr	-1%	+1.01%	Add
26	GPCR	Structure Therapeutics INC	-1.4%	—	Unchanged
27	RNAGBP	Avidity Biosciences INC	—	EXIT	Sold out
28	XBI	Ss Spdr S&p Biotech ETF	—	EXIT	Sold out
29	CYTK	Cytokinetics INC	—	NEW	New buy
30	DMRA	Damora Therapeutics INC	—	NEW	New buy
31	DFTX	Definium Therapeutics INC	—	NEW	New buy
32	BRD1EUR	Mind Medicine Mindmed INC	—	EXIT	Sold out
33	PTCT	Ptc Therapeutics INC	—	EXIT	Sold out
34	ORKA	Oruka Therapeutics INC	—	EXIT	Sold out
35	APGE	Apogee Therapeutics INC	—	EXIT	Sold out
36	AVTX	Avalo Therapeutics INC	—	NEW	New buy
37	INCY	Incyte CORP	—	EXIT	Sold out

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-15	13F-HR	View on EDGAR
2025-12-31	2026-03-16	Amendment	View on EDGAR
2025-12-31	2026-02-17	13F-HR	View on EDGAR
2025-09-30	2025-11-14	13F-HR	View on EDGAR
2025-06-30	2025-08-14	13F-HR	View on EDGAR
2025-03-31	2025-05-15	13F-HR	View on EDGAR
2024-12-31	2025-02-14	13F-HR	View on EDGAR
2024-09-30	2024-11-14	13F-HR	View on EDGAR
2024-06-30	2024-08-14	13F-HR	View on EDGAR
2024-03-31	2024-05-15	13F-HR	View on EDGAR
2023-12-31	2024-02-14	13F-HR	View on EDGAR
2023-09-30	2023-11-14	13F-HR	View on EDGAR
2023-06-30	2023-08-14	13F-HR	View on EDGAR
2023-03-31	2023-05-15	13F-HR	View on EDGAR
2022-12-31	2023-02-14	13F-HR	View on EDGAR
2022-09-30	2022-11-14	13F-HR	View on EDGAR
2022-06-30	2022-08-15	13F-HR	View on EDGAR
2022-03-31	2022-05-16	13F-HR	View on EDGAR
2021-12-31	2022-02-14	13F-HR	View on EDGAR
2021-09-30	2021-11-15	13F-HR	View on EDGAR
2021-06-30	2021-08-16	13F-HR	View on EDGAR
2021-03-31	2021-05-17	13F-HR	View on EDGAR
2020-12-31	2021-02-16	13F-HR	View on EDGAR
2020-09-30	2020-11-16	13F-HR	View on EDGAR
2020-06-30	2020-08-14	13F-HR	View on EDGAR
2020-03-31	2020-05-15	13F-HR	View on EDGAR
2019-12-31	2020-02-14	13F-HR	View on EDGAR
2019-09-30	2019-11-14	13F-HR	View on EDGAR
2019-06-30	2019-08-14	13F-HR	View on EDGAR
2019-03-31	2019-05-15	13F-HR	View on EDGAR
2018-12-31	2019-02-14	13F-HR	View on EDGAR
2018-09-30	2018-11-14	13F-HR	View on EDGAR
2018-06-30	2018-08-14	13F-HR	View on EDGAR
2018-03-31	2018-05-15	13F-HR	View on EDGAR
2017-12-31	2018-02-14	13F-HR	View on EDGAR
2017-09-30	2017-11-14	13F-HR	View on EDGAR
2017-06-30	2017-08-14	13F-HR	View on EDGAR
2017-03-31	2017-05-15	13F-HR	View on EDGAR
2016-12-31	2017-02-14	13F-HR	View on EDGAR
2016-09-30	2016-11-14	13F-HR	View on EDGAR
2016-06-30	2016-08-15	13F-HR	View on EDGAR
2016-03-31	2016-05-16	13F-HR	View on EDGAR
2015-12-31	2016-02-12	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-14	13F-HR	View on EDGAR
2015-03-31	2015-05-15	13F-HR	View on EDGAR
2014-12-31	2015-02-13	13F-HR	View on EDGAR

FAQ

What is Avoro Capital Advisors LLC and what type of investor is it?

Avoro Capital Advisors LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $10.2B, spread across 33 disclosed positions.

What are Avoro Capital Advisors LLC's largest equity positions?

Based on the latest 13F filing, Avoro Capital Advisors LLC's top holdings by market value are: 1. United Therapeutics CORP (UTHR) — $1.6B (15.4%) 2. Ascendis Pharma A/S (ASND) — $1.2B (11.4%) 3. Madrigal Pharmaceuticals INC (MDGL) — $951.8M (9.4%) 4. Krystal Biotech INC (KRYS) — $746.3M (7.3%) 5. Argenx Se - Adr (ARGX) — $730.3M (7.2%)

What changes did Avoro Capital Advisors LLC make in its most recent portfolio filing?

In the latest reported quarter, Avoro Capital Advisors LLC made 27 notable position adjustments: 4 new positions were initiated, 9 existing holdings were added to, 7 positions were partially reduced, and 7 were completely exited. The largest of these moves: Sold out: Avidity Biosciences INC (RNAGBP); Sold out: Ss Spdr S&p Biotech ETF (XBI); New buy: Cytokinetics INC (CYTK); New buy: Damora Therapeutics INC (DMRA); New buy: Definium Therapeutics INC (DFTX)

What sectors does Avoro Capital Advisors LLC focus on?

Avoro Capital Advisors LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%

Peer Institutions

Institutions with a similar AUM

Intech Investment Management LLC

CIK 0001086318

Total reported value

$10.2B

2,655 stks

2026-03-31

Concentration4.9

Portfolio Stability41.9

Sector conviction44.7

AUM within 0.0% of this institution

View detail

Gamco Investors, INC. Et Al

CIK 0000807249

Total reported value

$10.2B

1,007 stks

2026-03-31

Concentration2.1

Portfolio Stability16.4

Sector conviction54.4

AUM within 0.1% of this institution

View detail

Greenleaf Trust

CIK 0001162170

Total reported value

$10.2B

1,325 stks

2026-03-31

Concentration100.0

Portfolio Stability11.7

Sector conviction62.6

AUM within 0.1% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

Rtw Investments, LP

CIK 0001493215

Total reported value

$10.0B

88 stks

2026-03-31

Concentration14.9

Portfolio Stability36.5

Sector conviction100.0

2 of the top 5 holdings overlap, including Madrigal Pharmaceuticals INC

View detail

Rock Springs Capital Management LP

CIK 0001595725

Total reported value

$1.7B

100 stks

2026-03-31

Concentration10.3

Portfolio Stability35.5

Sector conviction100.0

2 of the top 5 holdings overlap, including Madrigal Pharmaceuticals INC

View detail

Frontier Capital Management Co LLC

CIK 0000351173

Total reported value

$9.7B

291 stks

2026-03-31

Concentration2.7

Portfolio Stability39.9

Sector conviction46.6

1 of the top 5 holdings overlap, including United Therapeutics CORP

View detail

Avoro Capital Advisors LLC Investment Portfolio — 13F Data

CIK: 0001633313

Momentum followerQuality / disciplined sizingDiversified strategy

Total reported value

$10.2B

Reporting period: 2026-03-31 · Number of holdings: 33

Avoro Capital Advisors LLC disclosed 33 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $10.2B and a quarterly turnover rate of 29.8%.

Browse other institutions with $10B to $100B AUM Browse other institutions starting with "A"

Personality snowflake

Concentration: 30.03
Portfolio Stability: 29.78
Momentum/Contrarian: 100
Sector conviction: 0
Diversification: 60
Sizing Uniformity: 88.62

Recent moves

Add UTHR
+15.5%　$300.0M
Add APLSUSD
0.0%　$184.7M
Trim GPCR
0.0%　-$140.0M
Add 430
+30.9%　$124.5M
Trim ARGX
+1.0%　-$102.3M
Trim MDGL
+0.6%　-$100.8M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 30 holdings (of 33 total)

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	UTHR	United Therapeutics CORP	Stock-Healthcare	15.44%	+2.96%	+15.50%
2	ASND	Ascendis Pharma A/S	Stock-Other	11.39%	+0.67%	-1.91%
3	MDGL	Madrigal Pharmaceuticals INC	Stock-Healthcare	9.36%	-0.99%	+0.59%
4	KRYS	Krystal Biotech INC	Stock-Healthcare	7.34%	+0.34%	—
5	ARGX	Argenx Se - Adr	Stock-Healthcare	7.18%	-1.00%	+1.01%
6	ARWR	Arrowhead Pharmaceuticals In	Stock-Healthcare	6.60%	-0.33%	+0.71%
7	KYMR	Kymera Therapeutics INC	Stock-Other	6.12%	+0.40%	—
8	APLSUSD	Apellis Pharmaceuticals INC	Stock-Other	4.84%	+1.82%	—
9	260	Centessa Pharmaceuticals-adr	Stock-Other	4.47%	+0.89%	-21.47%
10	CELC	Celcuity INC	Stock-Other	3.82%	+0.77%	+14.91%
11	XENE	Xenon Pharmaceuticals INC	Stock-Other	3.31%	+0.92%	+6.51%
12	GPCR	Structure Therapeutics INC	Stock-Other	3.11%	-1.37%	—
13	430	Terns Pharmaceuticals INC	Stock-Other	2.95%	+1.22%	+30.92%
14	VERA	Vera Therapeutics INC	Stock-Other	2.33%	-0.60%	—
15	RVMD	Revolution Medicines INC	Stock-Healthcare	2.24%	+0.54%	+8.04%
16	CYTK	Cytokinetics INC	Stock-Healthcare	2.16%	+2.16%	NEW
17	OCUL	Ocular Therapeutix INC	Stock-Other	1.03%	-0.26%	+14.26%
18	DMRA	Damora Therapeutics INC	Stock-Other	0.96%	+0.96%	NEW
19	QURE	uniQure N.V.	Stock-Other	0.96%	-0.49%	-3.10%
20	TSHA	Taysha Gene Therapies INC	Stock-Other	0.95%	-0.22%	—
21	DFTX	Definium Therapeutics INC	Stock-Other	0.93%	+0.93%	NEW
22	SLNOEUR	Soleno Therapeutics INC	Stock-Other	0.76%	-0.56%	-20.69%
23	ALKS	Alkermes plc	Stock-Healthcare	0.42%	+0.04%	-14.29%
24	SEPN	Septerna INC	Stock-Other	0.32%	-0.05%	—
25	VRDN	Viridian Therapeutics INC	Stock-Other	0.29%	-0.17%	—
26	GHRS	GH Research PLC	Stock-Other	0.25%	+0.03%	—
27	AVTX	Avalo Therapeutics INC	Stock-Other	0.21%	+0.21%	NEW
28	LXEO	Lexeo Therapeutics INC	Stock-Other	0.11%	-0.21%	-43.18%
29	WHWK	Whitehawk Therapeutics INC	Stock-Other	0.10%	+0.03%	—
30	MNKD	Mannkind CORP	Stock-Other	0.05%	-0.20%	-50.50%

Portfolio Performance

Performance for Q3 2026

+17.1%

Performance Last 4 Quarters

+91.1%

Based on 66% of reported portfolio value with available pricing

Stdev: +25%
Beta: +0.59
Alpha: +17.2%
Max Drawdown: -22.4%
Annualized Perf: +27.8%
Batting Avg vs S&P: +48.3%
Sortino: +2.03
Stutzer: +0.33
Treynor: +0.47
Sterling: +1.19
Calmar: +1.24
Information Ratio: +0.41
Tracking Error: +24.4%
Stdev Down: +13.7%
Winning Months %: +69%
Losing Months %: +31%
Best 12 Months: +107.3%
Worst 12 Months: -12.2%
Efficiency Ratio: +0.47
Sharpe: +1.11
Stdev Sectors: 0%
Skewness: -0.11
Kurtosis: -0.38
Upside Potential: +3.64

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	33	$10.2B	30	1UTHR 2ASND 3MDGL Top holdings2026-03-31 1.UTHR 2.ASND 3.MDGL 4.KRYS 5.ARGX 6.ARWR 7.KYMR 8.APLSUSD 9.260 10.CELC
2025-12-31	34	$10.2B	51	1UTHR 2ASND 3MDGL Top holdings2025-12-31 1.UTHR 2.ASND 3.MDGL 4.ARGX 5.KRYS 6.ARWR 7.KYMR 8.GPCR 9.RNAGBP 10.260
2025-09-30	32	$7.7B	48	1ASND 2UTHR 3MDGL Top holdings2025-09-30 1.ASND 2.UTHR 3.MDGL 4.ARGX 5.KRYS 6.ARWR 7.KYMR 8.N5749R 9.RNAGBP 10.APLSUSD
2025-06-30	30	$5.7B	0	1ASND 2UTHR 3ARGX Top holdings2025-06-30 1.ASND 2.UTHR 3.ARGX 4.MDGL 5.KRYS 6.KYMR 7.APLSUSD 8.RNAGBP 9.MLTX 10.AKRO
2025-03-31	33	$6.4B	100	1UTHR 2ASND 3ARGX Top holdings2025-03-31 1.UTHR 2.ASND 3.ARGX 4.MDGL 5.KRYS 6.2655787D 7.APLSUSD 8.RNAGBP 9.XENE 10.SLNOEUR
2024-12-31	39	$7.1B	0	1UTHR 2ARGX 3ASND Top holdings2024-12-31 1.UTHR 2.ARGX 3.ASND 4.MDGL 5.KRYS 6.APLSUSD 7.SRPT 8.ITCIEUR 9.VERA 10.XENE
2024-09-30	36	$6.9B	0	1UTHR 2ASND 3ARGX Top holdings2024-09-30 1.UTHR 2.ASND 3.ARGX 4.KRYS 5.MDGL 6.APLSUSD 7.SRPT 8.RNAGBP 9.AM6 10.ITCIEUR
2024-06-30	41	$7.5B	0	1UTHR 2MDGL 3ASND Top holdings2024-06-30 1.UTHR 2.MDGL 3.ASND 4.ARGX 5.SRPT 6.KRYS 7.APLSUSD 8.BMRN 9.CERE1EUR 10.XBI
2024-03-31	46	$8.6B	0	1UTHR 2APLSUSD 3ASND Top holdings2024-03-31 1.UTHR 2.APLSUSD 3.ASND 4.SRPT 5.MDGL 6.ARGX 7.KRYS 8.XBI 9.BMRN 10.AM6
2023-12-31	42	$7.2B	0	1APLSUSD 2UTHR 3ASND Top holdings2023-12-31 1.APLSUSD 2.UTHR 3.ASND 4.ARGX 5.MDGL 6.SRPT 7.BMRN 8.XBI 9.AM6 10.CERE1EUR
2023-09-30	46	$6.4B	0	1G461882UTHR 3ARGX Top holdings2023-09-30 1.G46188 2.UTHR 3.ARGX 4.SRPT 5.APLSUSD 6.SGENUSD 7.ASND 8.BMRN 9.AM6 10.KRYS
2023-06-30	43	$7.4B	0	1APLSUSD2G461883UTHR Top holdings2023-06-30 1.APLSUSD 2.G46188 3.UTHR 4.SRPT 5.ARGX 6.MDGL 7.BMRN 8.AM6 9.SGENUSD 10.ASND
2023-03-31	41	$6.7B	0	1G461882APLSUSD 3UTHR Top holdings2023-03-31 1.G46188 2.APLSUSD 3.UTHR 4.SRPT 5.ARGX 6.MDGL 7.BMRN 8.SGENUSD 9.ASND 10.AM6
2022-12-31	36	$6.7B	0	1UTHR2G461883APLSUSD Top holdings2022-12-31 1.UTHR 2.G46188 3.APLSUSD 4.MDGL 5.ARGX 6.SRPT 7.ASND 8.BMRN 9.AM6 10.ALNY
2022-09-30	39	$5.4B	0	1APLSUSD 2UTHR 3ARGX Top holdings2022-09-30 1.APLSUSD 2.UTHR 3.ARGX 4.MRTXEUR 5.SRPT 6.G46188 7.BMRN 8.ASND 9.AM6 10.SGENUSD
2022-06-30	40	$5.1B	0	1UTHR 2ARGX 3APLSUSD Top holdings2022-06-30 1.UTHR 2.ARGX 3.APLSUSD 4.G46188 5.MRTXEUR 6.AM6 7.BMRN 8.SGENUSD 9.SRPT 10.ASND
2022-03-31	43	$5.5B	0	1G461882UTHR 3APLSUSD Top holdings2022-03-31 1.G46188 2.UTHR 3.APLSUSD 4.MRTXEUR 5.ARGX 6.XBI 7.ASND 8.SRPT 9.BMRN 10.ALNY
2021-12-31	41	$5.9B	0	1G461882MRTXEUR 3UTHR Top holdings2021-12-31 1.G46188 2.MRTXEUR 3.UTHR 4.APLSUSD 5.ARGX 6.SRPT 7.ASND 8.BMRN 9.AM6 10.ALNY
2021-09-30	52	$6.4B	0	1G461882MRTXEUR 3XLRN Top holdings2021-09-30 1.G46188 2.MRTXEUR 3.XLRN 4.UTHR 5.ASND 6.ARGX 7.SRPT 8.IOVA 9.ARNAEUR 10.AM6
2021-06-30	46	$5.7B	100	1G461882MRTXEUR 3UTHR Top holdings2021-06-30 1.G46188 2.MRTXEUR 3.UTHR 4.XLRN 5.ARGX 6.ARNAEUR 7.ASND 8.IOVA 9.SRPT 10.ALNY
2021-03-31	46	$5.8B	43	1G461882MRTXEUR 3UTHR Top holdings2021-03-31 1.G46188 2.MRTXEUR 3.UTHR 4.XLRN 5.VRTX 6.ARNAEUR 7.ARGX 8.IOVA 9.043351 10.MDGL
2020-12-31	44	$5.8B	72	1MRTXEUR2G461883UTHR Top holdings2020-12-31 1.MRTXEUR 2.G46188 3.UTHR 4.IOVA 5.ARNAEUR 6.ASND 7.SRPT 8.ARGX 9.AM6 10.XLRN
2020-09-30	46	$7.0B	53	1IMMU 2MRTXEUR3G46188 Top holdings2020-09-30 1.IMMU 2.MRTXEUR 3.G46188 4.IOVA 5.ASND 6.MYOKEUR 7.ARGX 8.SRPT 9.ARNAEUR 10.AM6
2020-06-30	45	$5.1B	59	1IMMU 2MRTXEUR3G46188 Top holdings2020-06-30 1.IMMU 2.MRTXEUR 3.G46188 4.IOVA 5.SRPT 6.ASND 7.BMRN 8.ARGX 9.MYOKEUR 10.AM6
2020-03-31	43	$3.0B	41	1IMMU 2MRTXEUR 3IOVA Top holdings2020-03-31 1.IMMU 2.MRTXEUR 3.IOVA 4.ASND 5.BMRN 6.SRPT 7.G46188 8.KPTIEUR 9.ARGX 10.CNST
2019-12-31	32	$3.4B	57	1IMMU 2MRTXEUR 3ASND Top holdings2019-12-31 1.IMMU 2.MRTXEUR 3.ASND 4.IOVA 5.SRPT 6.CNST 7.BMRN 8.ARGX 9.G46188 10.QURE
2019-09-30	33	$2.4B	30	1MRTXEUR 2IMMU 3IOVA Top holdings2019-09-30 1.MRTXEUR 2.IMMU 3.IOVA 4.ASND 5.BMRN 6.023111 7.SRPT 8.G46188 9.ARGX 10.AM6
2019-06-30	35	$2.9B	42	1MRTXEUR 2IMMU 3IOVA Top holdings2019-06-30 1.MRTXEUR 2.IMMU 3.IOVA 4.ASND 5.SRPT 6.BMRN 7.023111 8.AM6 9.ARGX 10.ZGNXEUR
2019-03-31	32	$2.3B	45	1IMMU 2MRTXEUR 3ASND Top holdings2019-03-31 1.IMMU 2.MRTXEUR 3.ASND 4.023111 5.SRPT 6.AM6 7.G4617B 8.ZGNXEUR 9.ARGX 10.IOVA
2018-12-31	35	$1.7B	40	1IMMU 2MRTXEUR 3SRPT Top holdings2018-12-31 1.IMMU 2.MRTXEUR 3.SRPT 4.ASND 5.BMRN 6.AM6 7.IOVA 8.G4617B 9.ARGX 10.023111
2018-09-30	46	$2.2B	36	1IMMU 2MRTXEUR 3SRPT Top holdings2018-09-30 1.IMMU 2.MRTXEUR 3.SRPT 4.ASND 5.BMRN 6.AM6 7.MDGL 8.IOVA 9.29269A 10.G4617B
2018-06-30	44	$2.6B	63	1IMMU 2MRTXEUR 3BMRN Top holdings2018-06-30 1.IMMU 2.MRTXEUR 3.BMRN 4.AM6 5.ASND 6.MDGL 7.SRPT 8.IOVA 9.G4617B 10.29269A
2018-03-31	58	$2.1B	50	1IMMU 2AM6 3BMRN Top holdings2018-03-31 1.IMMU 2.AM6 3.BMRN 4.IOVA 5.MRTXEUR 6.ASND 7.GBTUSD 8.05366U 9.TGTX 10.G4617B
2017-12-31	52	$1.5B	47	1IMMU 2AM6 3BMRN Top holdings2017-12-31 1.IMMU 2.AM6 3.BMRN 4.MRTXEUR 5.CLVSEUR 6.GBTUSD 7.ARRYEUR 8.ASND 9.05366U 10.G4617B
2017-09-30	45	$1.3B	67	1IMMU 2AM6 3KRG Top holdings2017-09-30 1.IMMU 2.AM6 3.KRG 4.ARRYEUR 5.CLVSEUR 6.MDCOUSD 7.ASND 8.BMRN 9.PCRX 10.G4617B
2017-06-30	47	$792.0M	59	1IMMU 2KRG 3AM6 Top holdings2017-06-30 1.IMMU 2.KRG 3.AM6 4.T8S 5.BMRN 6.MDCOUSD 7.DERMEUR 8.87960W 9.ARRYEUR 10.IOVA
2017-03-31	47	$782.8M	81	1IMMU 2T8S 3MDCOUSD Top holdings2017-03-31 1.IMMU 2.T8S 3.MDCOUSD 4.ACAD 5.BMRN 6.DERMEUR 7.AM6 8.ARRYEUR 9.LION 10.GBTUSD
2016-12-31	44	$495.0M	53	1ACAD 2IMMU 3BMRN Top holdings2016-12-31 1.ACAD 2.IMMU 3.BMRN 4.LION 5.T8S 6.SRPT 7.M74231 8.DERMEUR 9.AERIEUR 10.NBIX
2016-09-30	48	$569.9M	64	1SRPT 2BMRN 3LION Top holdings2016-09-30 1.SRPT 2.BMRN 3.LION 4.T8S 5.AGENEUR 6.AM6 7.DERMEUR 8.ACAD 9.NBIX 10.IMMU
2016-06-30	48	$450.0M	81	1T8S 2LION315089R Top holdings2016-06-30 1.T8S 2.LION 3.15089R 4.BMRN 5.BMY 6.SRPT 7.NBIX 8.DERMEUR 9.AM6 10.IMMU
2016-03-31	41	$286.7M	81	1MRTXEUR 2AM6 3SRPT Top holdings2016-03-31 1.MRTXEUR 2.AM6 3.SRPT 4.BMRN 5.GILD 6.NBIX 7.LION 8.15089R 9.MODV 10.BMY
2015-12-31	31	$290.3M	52	1MRTXEUR 2AM6 3LION Top holdings2015-12-31 1.MRTXEUR 2.AM6 3.LION 4.LJPC 5.SRPT 6.71426V 7.DERMEUR 8.87960W 9.VNDA 10.SRNE
2015-09-30	36	$384.6M	61	1AM6 2MRTXEUR 3VNDA Top holdings2015-09-30 1.AM6 2.MRTXEUR 3.VNDA 4.M74231 5.LJPC 6.ACAD 7.71426V 8.LION 9.SRNE 10.SRPT
2015-06-30	31	$363.1M	86	1AM6 2SRNE 3MRTXEUR Top holdings2015-06-30 1.AM6 2.SRNE 3.MRTXEUR 4.LION 5.682324 6.ACAD 7.AGENEUR 8.VNDA 9.LJPC 10.449575
2015-03-31	33	$260.6M	91	1AM6 2LION 3SRNE Top holdings2015-03-31 1.AM6 2.LION 3.SRNE 4.151020 5.71426V 6.079481 7.AGENEUR 8.EBS 9.MRTXEUR 10.LJPC
2014-12-31	30	$147.6M	0	1AM62M8737E3756207 Top holdings2014-12-31 1.AM6 2.M8737E 3.756207 4.71426V 5.AGENEUR 6.SRNE 7.EBS 8.556099 9.682324 10.079481

Holding changes this quarter

Position changes disclosed by Avoro Capital Advisors LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	UTHR	United Therapeutics CORP	+3%	+15.50%	Add
2	APLSUSD	Apellis Pharmaceuticals INC	+1.8%	—	Unchanged
3	430	Terns Pharmaceuticals INC	+1.2%	+30.92%	Add
4	XENE	Xenon Pharmaceuticals INC	+0.9%	+6.51%	Add
5	260	Centessa Pharmaceuticals-adr	+0.9%	-21.47%	Trim
6	CELC	Celcuity INC	+0.8%	+14.91%	Add
7	ASND	Ascendis Pharma A/S	+0.7%	-1.91%	Trim
8	RVMD	Revolution Medicines INC	+0.5%	+8.04%	Add
9	KYMR	Kymera Therapeutics INC	+0.4%	—	Unchanged
10	KRYS	Krystal Biotech INC	+0.3%	—	Unchanged
11	ALKS	Alkermes plc	0%	-14.29%	Trim
12	WHWK	Whitehawk Therapeutics INC	0%	—	Unchanged
13	GHRS	GH Research PLC	0%	—	Unchanged
14	SEPN	Septerna INC	-0.1%	—	Unchanged
15	VRDN	Viridian Therapeutics INC	-0.2%	—	Unchanged
16	MNKD	Mannkind CORP	-0.2%	-50.50%	Trim
17	LXEO	Lexeo Therapeutics INC	-0.2%	-43.18%	Trim
18	TSHA	Taysha Gene Therapies INC	-0.2%	—	Unchanged
19	OCUL	Ocular Therapeutix INC	-0.3%	+14.26%	Add
20	ARWR	Arrowhead Pharmaceuticals In	-0.3%	+0.71%	Add
21	QURE	uniQure N.V.	-0.5%	-3.10%	Trim
22	SLNOEUR	Soleno Therapeutics INC	-0.6%	-20.69%	Trim
23	VERA	Vera Therapeutics INC	-0.6%	—	Unchanged
24	MDGL	Madrigal Pharmaceuticals INC	-1%	+0.59%	Add
25	ARGX	Argenx Se - Adr	-1%	+1.01%	Add
26	GPCR	Structure Therapeutics INC	-1.4%	—	Unchanged
27	RNAGBP	Avidity Biosciences INC	—	EXIT	Sold out
28	XBI	Ss Spdr S&p Biotech ETF	—	EXIT	Sold out
29	CYTK	Cytokinetics INC	—	NEW	New buy
30	DMRA	Damora Therapeutics INC	—	NEW	New buy
31	DFTX	Definium Therapeutics INC	—	NEW	New buy
32	BRD1EUR	Mind Medicine Mindmed INC	—	EXIT	Sold out
33	PTCT	Ptc Therapeutics INC	—	EXIT	Sold out
34	ORKA	Oruka Therapeutics INC	—	EXIT	Sold out
35	APGE	Apogee Therapeutics INC	—	EXIT	Sold out
36	AVTX	Avalo Therapeutics INC	—	NEW	New buy
37	INCY	Incyte CORP	—	EXIT	Sold out

Filing History

Period	Filed	Type	EDGAR
2026-03-31	2026-05-15	13F-HR	View on EDGAR
2025-12-31	2026-03-16	Amendment	View on EDGAR
2025-12-31	2026-02-17	13F-HR	View on EDGAR
2025-09-30	2025-11-14	13F-HR	View on EDGAR
2025-06-30	2025-08-14	13F-HR	View on EDGAR
2025-03-31	2025-05-15	13F-HR	View on EDGAR
2024-12-31	2025-02-14	13F-HR	View on EDGAR
2024-09-30	2024-11-14	13F-HR	View on EDGAR
2024-06-30	2024-08-14	13F-HR	View on EDGAR
2024-03-31	2024-05-15	13F-HR	View on EDGAR
2023-12-31	2024-02-14	13F-HR	View on EDGAR
2023-09-30	2023-11-14	13F-HR	View on EDGAR
2023-06-30	2023-08-14	13F-HR	View on EDGAR
2023-03-31	2023-05-15	13F-HR	View on EDGAR
2022-12-31	2023-02-14	13F-HR	View on EDGAR
2022-09-30	2022-11-14	13F-HR	View on EDGAR
2022-06-30	2022-08-15	13F-HR	View on EDGAR
2022-03-31	2022-05-16	13F-HR	View on EDGAR
2021-12-31	2022-02-14	13F-HR	View on EDGAR
2021-09-30	2021-11-15	13F-HR	View on EDGAR
2021-06-30	2021-08-16	13F-HR	View on EDGAR
2021-03-31	2021-05-17	13F-HR	View on EDGAR
2020-12-31	2021-02-16	13F-HR	View on EDGAR
2020-09-30	2020-11-16	13F-HR	View on EDGAR
2020-06-30	2020-08-14	13F-HR	View on EDGAR
2020-03-31	2020-05-15	13F-HR	View on EDGAR
2019-12-31	2020-02-14	13F-HR	View on EDGAR
2019-09-30	2019-11-14	13F-HR	View on EDGAR
2019-06-30	2019-08-14	13F-HR	View on EDGAR
2019-03-31	2019-05-15	13F-HR	View on EDGAR
2018-12-31	2019-02-14	13F-HR	View on EDGAR
2018-09-30	2018-11-14	13F-HR	View on EDGAR
2018-06-30	2018-08-14	13F-HR	View on EDGAR
2018-03-31	2018-05-15	13F-HR	View on EDGAR
2017-12-31	2018-02-14	13F-HR	View on EDGAR
2017-09-30	2017-11-14	13F-HR	View on EDGAR
2017-06-30	2017-08-14	13F-HR	View on EDGAR
2017-03-31	2017-05-15	13F-HR	View on EDGAR
2016-12-31	2017-02-14	13F-HR	View on EDGAR
2016-09-30	2016-11-14	13F-HR	View on EDGAR
2016-06-30	2016-08-15	13F-HR	View on EDGAR
2016-03-31	2016-05-16	13F-HR	View on EDGAR
2015-12-31	2016-02-12	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-14	13F-HR	View on EDGAR
2015-03-31	2015-05-15	13F-HR	View on EDGAR
2014-12-31	2015-02-13	13F-HR	View on EDGAR